CellWell record HH-47009
Investigating the relationship between thyroid replacement therapy goals status and quality of life in patients with primary hypothyroidism
Ayşe Kubat Üzüm; Zeynel Abidin Sayiner; Kader Uğur; Sadettin Öztürk; Güzide Gonca Örük; Ayten Eraydın; Havva Sezer; Abbas Ali Tam; Fatma Nur Korkmaz; Çiğdem Tura Bahadır; Ziynet Alphan Üç; Filiz Ekşi Haydardedeoğlu; Mehtap Evran; Barış Karagün; Emre Saygılı; Dilek Tüzün; Züleyha Karaca; Hülya Hacışahinoğulları; Gülhan Akbaba; Meriç Coşkun; Tayfun Garip; Müge Özsan Yılmaz; Eren Gürkan; Gökçen Ünal Kocabaş; Nurdan Gül; Mustafa Koçak; Ahmet Numan Demir; Güven Barış Cansu; Mustafa Kulaksızoğlu; Mustafa Ünübol; Murat Çalapkulu; Mehmet Muhittin Yalçın; Füsun Baloş Törüner; Mustafa Sait Gönen; Mehmet Erdoğan; Dilek Yazıcı; Bekir Çakır; Murat Faik Erdoğan; Ersin Akarsu
2026
In plain language
In 1750 patients with hypothyroidism on levothyroxine, those who less often reached their target TSH reported more fatigue, anxiety, depression and cognitive complaints, and lower overall quality of life.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-47009
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.